Suppr超能文献

储存在添加剂溶液中的高浓缩血小板:产量和体外质量方面

Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.

作者信息

Ringwald J, Walz S, Zimmermann R, Zingsem J, Strasser E, Weisbach V, Eckstein R

机构信息

Department for Transfusion Medicine and Haemostaseology, University Hospital of Erlangen, Erlangen, Germany.

出版信息

Vox Sang. 2005 Jul;89(1):11-8. doi: 10.1111/j.1423-0410.2005.00645.x.

Abstract

BACKGROUND AND OBJECTIVES

New platelet (PLT) additive solutions (PASs) allow a plasma carryover of < 30% in PLT concentrates. This implicates the need to collect apheresis PLT concentrates at very high PLT concentrations: so-called dry PLTs (DPs). We used the TRIMA, with software version 4 (TRIMA V4), to collect such DPs and investigated the in vitro quality of these PLTs when stored in the new modified PAS-III (PAS-IIIM).

MATERIALS AND METHODS

TRIMA V4 was programmed to collect 6.0 x 10(11) PLTs at a concentration of 5000 x 10(3) PLTs/microl. Two DPs were pooled, split into four equal parts and diluted to obtain secondary pools (SPs) consisting of 70% PAS-III/30% plasma, 70% PAS-IIIM/30% plasma, 80% PAS-IIIM/20% plasma or 100% plasma. In vitro testing was performed on days 0, 1, 5 and 7. Collection efficiency (CE), collection rate (CR) and PLT yield were calculated for each donation.

RESULTS

Thirty-two runs with TRIMA V4 were performed, collecting 6.58 +/- 0.74 x 10(11) PLTs at a concentration of 4255 +/- 914 x 10(3)/microl in 99 +/- 19.9 min, resulting in a CE of 65.3 +/- 8.2% and a CR of 6.92 +/- 1.6 x 10(9) PLTs/min. On day 0, 34-37% of the PLTs in the units prepared for storage were already activated. PLTs stored in 70% or 80% PAS-IIIM showed superior in vitro quality compared to PLTs stored in PAS-III.

CONCLUSIONS

TRIMA V4 is a suitable device for the collection of DPs. Nevertheless, improvements are desirable to further increase the ability to concentrate PLTs at very high levels. The storage of apheresis-derived PLTs in PAS III-M is a very promising approach, even at a plasma carryover of < 30%.

摘要

背景与目的

新型血小板(PLT)添加剂溶液(PASs)可使PLT浓缩物中的血浆残留率<30%。这意味着需要以非常高的PLT浓度采集单采PLT浓缩物:即所谓的干血小板(DPs)。我们使用配备软件版本4(TRIMA V4)的TRIMA采集此类DPs,并研究了将这些PLT储存在新型改良PAS-III(PAS-IIIM)中时的体外质量。

材料与方法

对TRIMA V4进行编程,以5000×10³个PLTs/微升的浓度采集6.0×10¹¹个PLTs。将两份DPs合并,分成四等份并稀释,以获得由70% PAS-III/30%血浆、70% PAS-IIIM/30%血浆、80% PAS-IIIM/20%血浆或100%血浆组成的二级样本(SPs)。在第0、1、5和7天进行体外检测。计算每次采集的采集效率(CE)、采集速率(CR)和PLT产量。

结果

使用TRIMA V4进行了32次采集,在99±19.9分钟内以4255±914×10³/微升的浓度采集了6.58±0.74×10¹¹个PLTs,采集效率为65.3±8.2%,采集速率为6.92±1.6×10⁹个PLTs/分钟。在第0天,准备储存的单位中34 - 37%的PLTs已经被激活。与储存在PAS-III中的PLTs相比,储存在70%或80% PAS-IIIM中的PLTs显示出更好的体外质量。

结论

TRIMA V4是采集DPs的合适设备。然而,仍需要改进以进一步提高在非常高的水平上浓缩PLTs的能力。即使血浆残留率<30%,将单采来源的PLTs储存在PAS III-M中也是一种非常有前景的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验